Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors.

Yi Zhang,Lei Liu,Yun-Li Peng,Yun-Zi Liu,Teng-Yun Wu,Xiao-Liang Shen,Jiang-Rui Zhou,Ding-Ya Sun,Ai-Jun Huang,Xia Wang,Yun-Xia Wang,Chun-Lei Jiang
DOI: https://doi.org/10.1111/cns.12170
2014-01-01
CNS Neuroscience & Therapeutics
Abstract:AimsThe NLRP3 inflammasome is a cytoplasmic multiprotein complex of the innate immune system that regulates the cleavage of interleukin-1 and interleukin-18 precursors. It can detect a wide range of danger signals and trigger a series of immune-inflammatory reactions. There were plenty of studies indicating that activation of the immune system played pivotal roles in depression. However, the underlying mechanisms of immune-depression interactions remained elusive and there was no report about the involvement of inflammasome activation in depression. MethodsWe established an acute depression mouse model with lipopolysaccharide to explore the involvement of inflammasome activation in depression. ResultsThe lipopolysaccharide-treated mice displayed depressive-like behaviors and pro-inflammatory cytokine interleukin-1 protein and mRNA levels significantly increased. The NLRP3 inflammasome mRNA expression level also significantly elevated in depressed mice brain. Pretreatment with the NLRP3 inflammasome inhibitor Ac-YVAD-CMK significantly abrogated the depressive-like behaviors induced by lipopolysaccharide. ConclusionThese data suggest for the first time that the NLRP3 inflammasome is involved in lipopolysaccharide-induced mice depressive-like behaviors. The NLRP3 inflammasome may be a central mediator between immune activation and depression, which raises the possibility that it may be a more specific target for the depression treatments in the near future.
What problem does this paper attempt to address?